Cargando…
Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta. Most cases are sporadic and its etiology is incompletely understood. However, increasing evidence suggests that oxidative stre...
Autores principales: | Shin, Dong-Ik, Oh, Young J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Brain and Neural Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984958/ https://www.ncbi.nlm.nih.gov/pubmed/24737941 http://dx.doi.org/10.5607/en.2014.23.1.65 |
Ejemplares similares
-
Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine
por: Chang, Jui-Chih, et al.
Publicado: (2021) -
6-Hydroxydopamine Induces Abnormal Iron Sequestration in BV2 Microglia by Activating Iron Regulatory Protein 1 and Inhibiting Hepcidin Release
por: Xu, Manman, et al.
Publicado: (2022) -
Oxidation of DJ-1 Induced by 6-Hydroxydopamine Decreasing Intracellular Glutathione
por: Miyama, Akiko, et al.
Publicado: (2011) -
The 1-Tosylpentan-3-one Protects against 6-Hydroxydopamine-Induced Neurotoxicity
por: Kao, Chien-Jen, et al.
Publicado: (2017) -
6-hydroxydopamine-mediated release of norepinephrine increases faecal excretion of Salmonella enterica serovar Typhimurium in pigs
por: Pullinger, Gillian D., et al.
Publicado: (2010)